Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Gastroenterology|July 5, 2001
Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis BE K Manesis, S J HadziyannisJournal of Hepatology|August 24, 1999
Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilot studyS J Hadziyannis, E K Manesis, A PapakonstantinouAlimentary Pharmacology & Therapeutics|January 6, 2006
A partially overlapping treatment course with lamivudine and interferon in hepatitis B e antigen-negative chronic hepatitis BE K Manesis, G V Papatheodoridis, S J HadziyannisJournal of Hepatology|September 1, 1994
Optic tract neuropathy complicating low-dose interferon treatmentE K Manesis, C Petrou, D Brouzas, et al.Transplantation Proceedings|June 21, 2007
Liver transplantation in Greek patients: epidemiological data, morbidity, and mortality of 71 patients from a single center with 6 years of mean follow-upE Tsochatzis, J Koskinas, E K Manesis, et al.Hepatology (Baltimore, Md.)|June 1, 1995
Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trialE K Manesis, G Giannoulis, P Zoumboulis, et al.Journal of Viral Hepatitis|January 16, 2008
Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infectionG V Papatheodoridis, N Chrysanthos, E Hadziyannis, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 1, 2004
Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazoleS Tsiodras, R Zafiropoulou, J Giotakis, et al.Alimentary Pharmacology & Therapeutics|April 4, 2001
Induction interferon therapy in naïve patients with chronic hepatitis C: increased end-of-treatment virological responses but absence of long-term benefitA S Hadziyannis, C Papaioannou, F Spanou, et al.Journal of Viral Hepatitis|February 22, 2005
Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis BG V Papatheodoridis, K Petraki, E Cholongitas, et al.Pageof 3